Sight Sciences, Inc. (SGHT) — Stock Valuation & Research

Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching…

SGHT key statistics

Price$9.49
Market cap$522.79M
SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
52-week range3.378-9.713
Beta2.45

Explore SGHT's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.